We are live on ! Find out more
USNA icon

Usana Health Sciences

180 hedge funds and large institutions have $994M invested in Usana Health Sciences in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.89% less ownership

Funds ownership: 54.8% → 53.91% (-0.89%)

4% less funds holding

Funds holding: 188 → 180 (-8)

20% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 69

25% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 24

43% less capital inflows, than outflows

Capital inflows: $39M | Capital outflows: $67.9M

60% less call options, than puts

Call options by funds: $841K | Put options by funds: $2.1M

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
180
Holders Change
-8
Holders Change %
-4.26%
% of All Funds
3.14%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
55
Reduced
69
Closed
24
Calls
$841​K
Puts
$2.1​M
Net Calls
-⁠$1.26​M
Net Calls Change
-⁠$565​K

USNA Hedge Fund Activity: Q3 2021 in Review

180 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2021, worth a combined $994M — down 12% from $1.14B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of USNA and 18 opened new positions — a net loss of 6 holders — while 69 trimmed existing stakes and 55 added.

The largest buyer was Pzena Investment Management, opening a new position worth an estimated $9.21M. The largest seller was Arrowstreet Capital, cutting an estimated $9.8M.

  • 180 institutional investors held Usana Health Sciences (USNA) as of Q3 2021, down from 188 in Q2 2021.
  • Funds reported $994M of Usana Health Sciences stock for Q3 2021, down 12% quarter-over-quarter.
  • 18 funds opened new Usana Health Sciences positions in Q3 2021 and 24 closed out, a net change of -6 holders.
  • The largest Usana Health Sciences buyer in Q3 2021 was Pzena Investment Management, an estimated $9.21M added.
  • The largest Usana Health Sciences seller in Q3 2021 was Arrowstreet Capital, an estimated $9.8M sold.

Based on aggregated 13F filings for Q3 2021.